Bahij Ghazal, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 440 E Huntington Dr, Arcadia, CA 91006 Phone: 626-254-2293 |
News Archive
Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis (NASH) with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.
If a person's blood becomes too thick it can damage blood vessels and increase the risk of heart attacks. But a Temple University physicist has discovered that he can thin the human blood by subjecting it to a magnetic field.
mOm has raised £630,000 in seed funding from a prominent set of investors to further develop its revolutionary baby incubator. Led by MaSa Partners (a US-based impact fund), investors include Holly Branson (as part of the Virgin Group), Lord Rumi Verjee (as part of the The Rumi Foundation), Continuity Capital, Dr. Joshua Boger, Johannes Heine, Rockspring, and The London Co Investment Fund.
The increasing incidence of allergic skin diseases, and the accompanying economic burden and heightened risk of developing other allergic conditions, have spurred researchers to look for better ways to control these immune system-based disorders.
Tensys Medical, Inc., a leader in the development and commercialization of continuous, non-invasive hemodynamic patient monitoring systems, announced that a scientific paper evaluating the use of the company's T-line technology has been published in the British Journal of Anesthesia (03/13/13—advance online publication).
› Verified 2 days ago